Physician profile
Grazyna Tycner
NPI 1710181300
$975.84
in general payments reported to CMS, 2019-2025
7 companies · $872 in 2025
The $872 reported for 2025 was more than what 79% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.72 · 2020: $12.13 · 2022: $34.05 · 2024: $19.48 · 2025: $872.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $480 · Travel and Lodging: $412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $479.85 |
| Travel and Lodging | $412.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuronetics, INC. | $800.22 | 2025 | Neurostar Tms Therapy System |
| Alkermes, INC. | $51.48 | 2025 | Aristada, Aristada Initio, Vivitrol |
| Otsuka America Pharmaceutical, INC. | $40.24 | 2024-2025 | Abilify Asimtufii, Abilify Maintena |
| Neurocrine Biosciences, INC. | $34.05 | 2022 | |
| Vanda Pharmaceuticals INC. | $20.43 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $17.29 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grazyna Tycner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.